AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Anglim-Plus Tablet ER

Prescription Icon
Prescription Required

Marketer

Anabolic Remedies Pvt Ltd

Salt Composition

Glimepiride (2mg) + Metformin (500mg)

Overview Anglim-Plus Tablet ER

DiaBeta Duo ER tablets are classified as antidiabetic medications. This dual-action formulation treats type 2 diabetes in adults by managing blood glucose levels. DiaBeta Duo ER should be ingested with meals, consistently at the same time daily for optimal effectiveness. Dosage is determined and adjusted by your physician based on your blood sugar response. Continuous use is crucial, even with controlled blood sugar, as abrupt cessation can elevate glucose levels, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. This medication complements a comprehensive diabetes management plan, including dietary modifications, regular physical activity, and weight management as directed by your healthcare provider. Lifestyle choices significantly influence diabetes control. Hypoglycemia (low blood sugar) is a common side effect, characterized by sweating, lightheadedness, headaches, and tremors. Regular meals and readily available glucose sources (e.g., sugary snacks, fruit juice) are essential preventative measures. Alcohol consumption should be minimized due to its potential to exacerbate hypoglycemia. Other possible side effects include altered taste, nausea, diarrhea, abdominal discomfort, cephalalgia, and upper respiratory infections. Weight gain is a potential consequence for some users. DiaBeta Duo ER is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Prior heart conditions should be disclosed to your physician before commencing treatment. Pregnant or lactating individuals require medical consultation before use. Regular blood glucose monitoring and periodic blood tests (to assess blood cell counts and liver function) are recommended.

Primary Ingredients of Anglim-Plus Tablet ER

There is no text provided to rewrite.

Uses of Anglim-Plus Tablet ER

Managing type 2 diabetes

Major Benefits of Anglim-Plus Tablet ER:

Follow your physician's instructions precisely regarding dosage and treatment length for Anglim-Plus Tablet ER. Ingest the tablet whole; avoid chewing, crushing, or breaking it. Administer this medication with a meal.

Common Side effects of Anglim-Plus Tablet ER:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Anglim-Plus Tablet ER:

Follow your physician's instructions precisely regarding dosage and treatment length for Anglim-Plus Extended-Release Tablets. Ingest the tablets whole; do not chew, crush, or divide them. Administer this medication with a meal.

How Anglim-Plus Tablet ER works:

Anglim-Plus ER tablets contain glimepiride and metformin, two antidiabetic agents. Glimepiride, a sulfonylurea, stimulates pancreatic insulin release, thus reducing blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose uptake, and enhancing insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol while taking Anglim-Plus Tablet ER is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

Extended-release Anglim-Plus tablets might pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against potential hazards prior to prescribing. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Extended-release Anglim-Plus tablets are contraindicated during lactation. Evidence indicates potential infant toxicity from this medication.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Exercise caution when administering Anglim-Plus Tablet ER to individuals with impaired kidney function; dosage modification may be necessary. Consult a physician for guidance. Anglim-Plus Tablet ER is contraindicated in patients exhibiting severe kidney disease. Routine monitoring of renal function is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Anglim-Plus Extended-Release tablets cautiously, potentially requiring dosage modification. Consultation with a physician is advised. For those with mild to moderate hepatic dysfunction, initiation should be at a reduced dose; however, the medication is contraindicated in patients with severe liver disease.

What if you forget to take Anglim-Plus Tablet ER :

Should you forget to take an Anglim-Plus Tablet ER, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Anglim-Plus Tablet ER

LabelValue
Potential for Dependence None.
Type of Medication Medication for diabetes

FAQs on Anglim-Plus Tablet ER

Store the medication in its original, tightly sealed container or packaging, following all storage instructions provided on the label. Discard any leftover medication. Prevent access by children, pets, and other individuals.
Indeed, Anglim-Plus Tablet ER can cause lactic acidosis, a serious medical condition characterized by excessive blood lactic acid. This is also termed Metformin-associated lactic acidosis (MALA). While infrequent, this adverse reaction linked to metformin poses a significant risk to individuals with pre-existing kidney impairment, the elderly, or those who consume substantial alcohol. Symptoms may manifest as muscle aches or weakness, vertigo, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal discomfort, or bradycardia. Should you experience any of these, discontinue Anglim-Plus Tablet ER and seek immediate medical attention.
Anglim-Plus ER tablets contain glimepiride and metformin, two medications used together to manage type 2 diabetes mellitus in adults. The combination helps regulate blood sugar when used concurrently with a healthy diet and exercise program. Glimepiride stimulates insulin release from the pancreas, reducing blood glucose. Metformin reduces hepatic glucose production and enhances insulin sensitivity. This dual-drug therapy is unsuitable for individuals with type 1 diabetes.
Anglim-Plus Extended-Release tablets may cause common side effects including low blood sugar, taste changes, nausea, abdominal pain, diarrhea, and headache. Rare but potentially serious adverse reactions such as lactic acidosis may occur. Prolonged use can result in Vitamin B12 deficiency.
Prolonged Anglim-Plus Tablet ER use can indeed lead to Vitamin B12 deficiency by impeding its gastrointestinal absorption. This deficiency, if left unaddressed, may result in anemia, neurological complications such as peripheral neuropathy (manifesting as tingling, numbness in extremities, and weakness), urinary dysfunction, cognitive changes, and ataxia. Preventive strategies proposed by some researchers include annual supplemental Vitamin B12 intake.
Anglim-Plus Extended-Release tablets can induce hypoglycemia, characterized by low blood glucose. Manifestations of low blood sugar include nausea, headache, irritability, hunger, sweating, dizziness, tachycardia, and feelings of anxiety or tremor. The risk increases with missed or delayed meals, alcohol consumption, excessive physical activity, or concomitant use of other antidiabetic medications. Therefore, consistent blood glucose monitoring is crucial. Carrying a readily available fast-acting carbohydrate source, such as glucose tablets, honey, or fruit juice, is recommended.
Combining Anglim-Plus Tablet ER and alcohol is unsafe. This combination may cause dangerously low blood sugar (hypoglycemia) and raise the risk of lactic acidosis.
Anglim-Plus Tablet ER
53
MRP 65
18% off